Posts tagged with ‘faqs’

Is the recent BMS-Nektar NKTR-214 deal really the most lucrative agreement in biotech history?
Bristol-Myers Squibb (BMS) and Nektar Therapeutics (Nektar) have agreed to a Global Development & Commercialisation Collaboration, to work on Nektar’s…
Innofy Present at Global Innovation Conference
The IP team at Innofy were recently invited to present at the Global Creative Innovation Conference 2017 in Melbourne, Australia.…
Is the U.S. Supreme Court Deciding The Future Of Patent Invalidation Proceedings?
The Supreme Court of the United States (SCOTUS) is currently deliberating whether the United States Patent and Trade Mark Office…